A Murine Model for Human Sepiapterin-reductase Deficiency

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 2006 Mar 15

PMID 16532389

Citations 28

Authors

Seungkyoung Yang

Young Jae Lee

Jin-Man Kim

Sean Park

Joanna Peris

Philip Laipis

Young Shik Park

Jae Hoon Chung

S Paul Oh

Affiliations

Soon will be listed here.

Abstract

Tetrahydrobiopterin (BH(4)) is an essential cofactor for several enzymes, including all three forms of nitric oxide synthases, the three aromatic hydroxylases, and glyceryl-ether mono-oxygenase. A proper level of BH(4) is, therefore, necessary for the metabolism of phenylalanine and the production of nitric oxide, catecholamines, and serotonin. BH(4) deficiency has been shown to be closely associated with diverse neurological psychiatric disorders. Sepiapterin reductase (SPR) is an enzyme that catalyzes the final step of BH(4) biosynthesis. Whereas the number of cases of neuropsychological disorders resulting from deficiencies of other catalytic enzymes involved in BH(4) biosynthesis and metabolism has been increasing, only a handful of cases of SPR deficiency have been reported, and the role of SPR in BH(4) biosynthesis in vivo has been poorly understood. Here, we report that mice deficient in the Spr gene (Spr(-/-)) display disturbed pterin profiles and greatly diminished levels of dopamine, norepinephrine, and serotonin, indicating that SPR is essential for homeostasis of BH(4) and for the normal functions of BH(4)-dependent enzymes. The Spr(-/-) mice exhibit phenylketonuria, dwarfism, and impaired body movement. Oral supplementation of BH(4) and neurotransmitter precursors completely rescued dwarfism and phenylalanine metabolism. The biochemical and behavioral characteristics of Spr(-/-) mice share striking similarities with the symptoms observed in SPR-deficient patients. This Spr mutant strain of mice will be an invaluable resource to elucidate many important issues regarding SPR and BH(4) deficiencies.

Citing Articles

Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy.

Cronin S, Andrews N, Latremoliere A Front Pharmacol. 2023; 14:1173599.

PMID: 37251335 PMC: 10213231. DOI: 10.3389/fphar.2023.1173599.

Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons.

Cronin S, Yu W, Hale A, Licht-Mayer S, Crabtree M, Korecka J bioRxiv. 2023; .

PMID: 37214873 PMC: 10197517. DOI: 10.1101/2023.05.08.539795.

Exploring the Mystery of the Tetrahydrobiopterin Synthetic Defect Lethal Mutant from Birth to Death in the Silkworm .

Liang D, Shu R, Jiang S, Xu M, Cai Y, Qin H Int J Mol Sci. 2022; 23(20).

PMID: 36292934 PMC: 9603568. DOI: 10.3390/ijms232012083.

An atlas of transcriptionally defined cell populations in the rat ventral tegmental area.

Phillips 3rd R, Tuscher J, Black S, Andraka E, Fitzgerald N, Ianov L Cell Rep. 2022; 39(1):110616.

PMID: 35385745 PMC: 10888206. DOI: 10.1016/j.celrep.2022.110616.

WSV056 Inhibits Shrimp Nitric Oxide Synthase Activity by Downregulating Sepiapterin Reductase to Promote White Spot Syndrome Virus Replication.

Wang W, Zheng Q, Yu C, Pan C, Luo P, Chen J Front Microbiol. 2022; 12:796049.

PMID: 35003027 PMC: 8733705. DOI: 10.3389/fmicb.2021.796049.

References

Lee S, Park I, Hahn Y, Lee J, Seong C, Chung J . Cloning of mouse sepiapterin reductase gene and characterization of its promoter region. Biochim Biophys Acta. 1999; 1445(1):165-71. DOI: 10.1016/s0167-4781(99)00030-5. View

Levine R, Kapatos G, Kaufman S, Milstien S . Immunological evidence for the requirement of sepiapterin reductase for tetrahydrobiopterin biosynthesis in brain. J Neurochem. 1990; 54(4):1218-24. DOI: 10.1111/j.1471-4159.1990.tb01951.x. View

Nandi M, Miller A, Stidwill R, Jacques T, Lam A, Haworth S . Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse. Circulation. 2005; 111(16):2086-90. DOI: 10.1161/01.CIR.0000163268.32638.F4. View

Khoo J, Zhao L, Alp N, Bendall J, Nicoli T, Rockett K . Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension. Circulation. 2005; 111(16):2126-33. DOI: 10.1161/01.CIR.0000162470.26840.89. View

Neville B, Parascandalo R, Farrugia R, Felice A . Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder. Brain. 2005; 128(Pt 10):2291-6. DOI: 10.1093/brain/awh603. View

Fiege B, Bonafe L, Ballhausen D, Baumgartner M, Thony B, Meili D . Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study. Mol Genet Metab. 2005; 86 Suppl 1:S91-5. DOI: 10.1016/j.ymgme.2005.09.014. View

Thony B, Auerbach G, Blau N . Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J. 2000; 347 Pt 1:1-16. PMC: 1220924. View

FITZPATRICK P . Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem. 2000; 68:355-81. DOI: 10.1146/annurev.biochem.68.1.355. View

HUTTENLOCHER P . The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr. 2000; 159 Suppl 2:S102-6. DOI: 10.1007/pl00014371. View

10.

Szczypka M, Kwok K, Brot M, Marck B, Matsumoto A, Donahue B . Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron. 2001; 30(3):819-28. DOI: 10.1016/s0896-6273(01)00319-1. View

11.

Terpstra A . Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate. J Nutr. 2001; 131(7):2067-8. DOI: 10.1093/jn/131.7.2067. View

12.

Bonafe L, Thony B, Penzien J, CZARNECKI B, Blau N . Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet. 2001; 69(2):269-77. PMC: 1235302. DOI: 10.1086/321970. View

13.

Blau N, Bonafe L, Thony B . Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab. 2001; 74(1-2):172-85. DOI: 10.1006/mgme.2001.3213. View

14.

Urano F, Kuroda R, Ohye T, Kojima M, Tazawa M, Shiraishi H . Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice. J Biol Chem. 2001; 276(44):41150-60. DOI: 10.1074/jbc.M102237200. View

15.

Zorzi G, Redweik U, Trippe H, Penzien J, Thony B, Blau N . Detection of sepiapterin in CSF of patients with sepiapterin reductase deficiency. Mol Genet Metab. 2002; 75(2):174-7. DOI: 10.1006/mgme.2001.3273. View

16.

Diaz-Torga G, Feierstein C, Libertun C, Gelman D, Kelly M, Low M . Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. Endocrinology. 2002; 143(4):1270-9. DOI: 10.1210/endo.143.4.8750. View

17.

Spaapen L, Rubio-Gozalbo M . Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency, state of the art. Mol Genet Metab. 2003; 78(2):93-9. DOI: 10.1016/s1096-7192(02)00229-9. View

18.

Breier B, Gallaher B, Gluckman P . Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J Endocrinol. 1991; 128(3):347-57. DOI: 10.1677/joe.0.1280347. View

19.

Park Y, Heizmann C, Wermuth B, Levine R, Steinerstauch P, Guzman J . Human carbonyl and aldose reductases: new catalytic functions in tetrahydrobiopterin biosynthesis. Biochem Biophys Res Commun. 1991; 175(3):738-44. DOI: 10.1016/0006-291x(91)91628-p. View

20.

Tybulewicz V, Crawford C, Jackson P, Bronson R, Mulligan R . Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 1991; 65(7):1153-63. DOI: 10.1016/0092-8674(91)90011-m. View